Barley
Intervention1 paper3 findings
- Human trial1
Outcomes
3Vascular cell adhesion molecule
downin humans1Low certainty
1 study
Vascular cell adhesion molecule
downin humans1Low certainty
Barley decreases vascular cell adhesion molecule in humans.
Human trial4 daily servings per 2000 kcal6 weeksn = 68
Whole Grain Oats and Barley Products Modify Lipoproteins and Cardiometabolic Risk Markers in Adults: A 6-Week, Double-Blind, Parallel Design, Randomized Controlled Feeding Trial · Nutrients · 2 Sep 2026
Diastolic blood pressure
downin humans1Low certainty
1 study
Diastolic blood pressure
downin humans1Low certainty
Barley decreases diastolic blood pressure in humans.
Human trial4 daily servings per 2000 kcal6 weeksn = 68
Whole Grain Oats and Barley Products Modify Lipoproteins and Cardiometabolic Risk Markers in Adults: A 6-Week, Double-Blind, Parallel Design, Randomized Controlled Feeding Trial · Nutrients · 2 Sep 2026
Total VLDL and chylomicron particles
downin humans1Low certainty
1 study
Total VLDL and chylomicron particles
downin humans1Low certainty
Barley decreases total VLDL and chylomicron particles in humans.
Human trial4 daily servings per 2000 kcal6 weeksn = 68
Whole Grain Oats and Barley Products Modify Lipoproteins and Cardiometabolic Risk Markers in Adults: A 6-Week, Double-Blind, Parallel Design, Randomized Controlled Feeding Trial · Nutrients · 2 Sep 2026